Trial
NCT05691478
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase IISUSPENDEDOTHER/UNKNOWNConfidence: LOW
Sponsor
National Cancer Institute (NCI)
Collaborators
—
Condition
High Grade Osteosarcoma
Intervention
Bone Scan
Why stopped
Other - Extend the observation period for current patients
Provenance
Dataset: 2026-08-14 • Source: ClinicalTrials.gov API v2 • Last update: 2026-08-14